Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A strong index level often signals robust momentum and potential persistence. Interpret carefully to adjust positions and risk exposure.
24,569 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A private AI platform reports 1.5 million users and opens a new round at sub-$1, inviting retail investors. The compa...
SoftBank dismisses Elon Musk’s orbital data center idea, choosing immediate Earth-based expansion. The move comes as ...
Cardano ADA is trading within a tight range as traders weigh the ghost chain label and upcoming ecosystem development...
Crypto gaming platform 1Win unveils a native token and dual-chain Web3 ecosystem to embed token utility across gaming...
Palo Alto Networks has surged about a month’s worth of gains, fueling a debate on whether to book profits and rotate ...
As lenders chase ROI from AI, a governance-first pivot for mortgage workflows is gaining steam. Banks report better a...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...
Meta Platforms unveils a multi-year AI infrastructure plan with Nvidia valued around $115 billion to $135 billion for...
Navy SEALs depend on cutting-edge sensors, optics, and targeting gear to shape battles before they start. That relian...
Rolex opens a tuition-free watchmaking training center in Dallas to tackle a shrinking U.S. talent pool, drawing hund...
Stevanato Group (STVN) is shaping 2025 earnings visibility with a solid Q4 performance and cautious optimism for 2026...